NCT06417034

Hand Training Device For Cognitive Care

National Cheng-Kung University Hospital·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Game Software
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
National Cheng-Kung University Hospital
Location
Tainan, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Mar 27, 2022
End date
Aug 09, 2023
Enrollment
82 participants
Primary outcome

Oxygenated hemoglobin (HbO),Montreal Cognitive Assessment (MoCA) test,EN value

Summary

Previous studies indicated that auditory stimulation as an external cue might have positive
 impacts on sensorimotor synchronization. Additionally, according to previous reports apart
 from traditional interventions, digitized game-based device, such as FTOMBVG, are beneficial
 for the brain activation in elderly. [27]. Moreover, enhanced finger force control and
 coordination lead to better hand dexterity and is believed to eventually improve life
 independence in the healthy elderly and the elderly with cognitive decline. Therefore, this
 study aims to develop an advanced systems based on the previous one, that can provide hand
 function rehabilitation, cognitive training, and emotional comfort for the elderly or people
 suffer from cognitive deficiency. They can enhance their finger force control or visual to
 motor synchronization by music embedded during the gaming process.

ICD-10 classifications
Mild cognitive disorderAlzheimer disease, unspecifiedAlzheimer diseaseDementia in Alzheimer disease, unspecifiedAlzheimer disease with late onset
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06417034
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06417034 through Pure Global AI's free database. This phase not specified trial is sponsored by National Cheng-Kung University Hospital and is currently Completed. The study focuses on Healthy Elderly,Mild Cognitive Impairment (MCI). Target enrollment is 82 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.